RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Cary, NC · Chapel Hill, NC · +119 more sites
5 recruiting psoriasis studies with a site in Chapel Hill, NC.
Sponsor: Bristol-Myers Squibb
Cary, NC · Chapel Hill, NC · +119 more sites
Sponsor: Janssen Research & Development, LLC
Chapel Hill, NC
Sponsor: UCB Biopharma SRL
Chapel Hill, NC · Durham, NC · +4 more sites
Sponsor: AbbVie
Chapel Hill, NC · +11 more sites
Sponsor: Duke University
Chapel Hill, NC · Charlotte, NC · Durham, NC · +72 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.